No increase seen in CV events in elderly after BNT162b2 vaccination
Dutch give green light for Pfizer shots for children over 5
10 December 2021Speaking “baby talk” to infants isn’t just cute: It could help them learn to make words
10 December 2021No increase seen in CV events in elderly after BNT162b2 vaccination
(HealthDay)—In the 14 days following each of the two doses of BNT162b2 mRNA vaccine, there was no increase in the incidence of acute myocardial infarction, stroke, or pulmonary embolism among individuals aged 75 years or older from France, according to a research letter published online Nov. 22 in the Journal of the American Medical Association.
